Institutional investors control 46.41% of the outstanding shares in GERN. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended March 2015, these large investors purchased a net $4.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AMERICAN CENTURY INVESTMENT MANA... Bought 643.8 Thousand shares of Geron Corp